A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Net Income | -35M | -35M | -32M | -28M | -22M |
| EPS | $-1.32 | $-1.32 | $-1.42 | $-1.53 | $-1.44 |
| Free Cash Flow | -32M | -32M | -30M | -28M | -20M |
| ROIC | -225.7% | -225.7% | -85.3% | -121.5% | -98.8% |
| Gross Margin | - | - | - | - | - |
| Debt/Equity | 0.00 | - | - | - | 72.14 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -31M | -31M | -30M | -27M | -20M |
| Operating Margin | 0.0% | - | - | - | - |
| ROE | 0.0% | - | - | - | -16944.0% |
| Shares Outstanding | 27M | 27M | 23M | 18M | 15M |
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -20M | -27M | -30M | -31M | -31M |
| Op. Margin | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -22M | -28M | -32M | -35M | -35M |
| Net Margin | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -98.8% | -121.5% | -85.3% | N/M | N/M |
| ROE | -16944.0% | N/A | N/A | N/A | 0.0% |
| ROA | -134.4% | -160.6% | -118.2% | -322.4% | -322.4% |
| Cash Flow | |||||
| Op. Cash Flow | -20M | -28M | -29M | -32M | -32M |
| Free Cash Flow | -20M | -28M | -30M | -32M | -32M |
| Owner Earnings | -20M | -29M | -30M | -32M | -32M |
| CapEx | 158K | 384K | 713K | 772K | 772K |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | 772K |
| D&A | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 294K | 633K | 594K | 612K | 612K |
| Debt Repayment | 3.7M | 0 | 0 | 1.1M | 1.1M |
| Balance Sheet | |||||
| Net Debt | -3.3M | -1.5M | -6.2M | 8.2M | -2.8M |
| Cash & Equiv. | 13M | 11M | 20M | 2.8M | 2.8M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 72.14 | N/A | N/A | N/A | 0.00 |
| Interest Coverage | -13.2 | -26.5 | -10.3 | -6.7 | -6.7 |
| Equity | 129K | -929K | -2.3M | -21M | -21M |
| Total Assets | 16M | 17M | 27M | 11M | 11M |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Intangibles | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -137M | -168M | -183M | -224M | -224M |
| Working Capital | 8.6M | 6.7M | 8.4M | -14M | -14M |
| Current Assets | 15M | 15M | 24M | 6.8M | 6.8M |
| Current Liabilities | 6.9M | 8.5M | 16M | 21M | 21M |
| Per Share Data | |||||
| EPS | -1.44 | -1.53 | -1.42 | -1.32 | -1.32 |
| Owner EPS | -1.30 | -1.57 | -1.30 | -1.21 | -1.21 |
| Book Value | 0.01 | -0.05 | -0.10 | -0.79 | -0.79 |
| Cash Flow/Share | 0.00 | 0.00 | 0.00 | 0.00 | -1.32 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 15.3M | 18.2M | 22.8M | 26.7M | 26.7M |
| Valuation | |||||
| P/E Ratio | -7.6 | -5.5 | -4.7 | -3.3 | -0.4 |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | -11.8% | -18.3% | -19.5% | -27.4% | -249.7% |
| Market Cap | 166M | 154M | 152M | 118M | 13M |
| Avg. Price | 7.33 | 9.73 | 6.54 | 4.28 | 0.49 |
| Year-End Price | 10.87 | 8.49 | 6.67 | 4.42 | 0.49 |
SEQUANA MEDICAL passes 0 of 9 quality checks, indicating weak fundamentals.
SEQUANA MEDICAL (SEQUA-BR) has a 5-year average return on invested capital (ROIC) of -101.8%. This is below average and may indicate limited pricing power.
SEQUANA MEDICAL (SEQUA-BR) has a market capitalization of $13M. It is classified as a small-cap stock.
SEQUANA MEDICAL (SEQUA-BR) does not currently pay a regular dividend.
SEQUANA MEDICAL (SEQUA-BR) generated $-32 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
SEQUANA MEDICAL (SEQUA-BR) reported earnings per share (EPS) of $-1.32 in its most recent fiscal year.
The Ledger Terminal provides 4 years of financial data for SEQUANA MEDICAL (SEQUA-BR), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
SEQUANA MEDICAL (SEQUA-BR) has a book value per share of $-0.79, based on its most recent annual SEC filing.